Characterization of the Surface Expression of PD-1/PD-L1 Signaling Proteins in High-Grade Serous Ovarian Carcinoma

被引：0
|
作者：
Yoon, Ju-Yoon
Stewart, Jocelyn M.
Go, Christopher
Bernardini, Marcus
Clarke, Blaise
Shaw, Patricia
Neel, Benjamin
Allies, Laurie
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Univ Hlth Network, Toronto, ON, Canada
[3] NYU Langone Med Ctr, Bronxville, NY USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1275
引用
收藏
页码：317A / 318A
页数：2
相关论文
共 50 条
  • [1] Characterization of the Surface Expression of PD-1/PD-L1 Signaling Proteins in High-Grade Serous Ovarian Carcinoma
    Yoon, Ju-Yoon
    Stewart, Jocelyn M.
    Go, Christopher
    Bernardini, Marcus
    Clarke, Blaise
    Shaw, Patricia
    Neel, Benjamin
    Ailles, Laurie
    LABORATORY INVESTIGATION, 2017, 97 : 317A - 318A
  • [2] The expression of PD-1/PD-L1 in high-grade serous ovarian carcinoma and its metastases
    Unger, C.
    Bronsert, P.
    Juhasz-Boess, I
    Kurowski, K.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (10) : E175 - E175
  • [3] PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
    Laura Martin de la Fuente
    Sofia Westbom-Fremer
    Nicolai Skovbjerg Arildsen
    Linda Hartman
    Susanne Malander
    Päivi Kannisto
    Anna Måsbäck
    Ingrid Hedenfalk
    Virchows Archiv, 2020, 477 : 83 - 91
  • [4] PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
    de la Fuente, Laura Martin
    Westbom-Fremer, Sofia
    Arildsen, Nicolai Skovbjerg
    Hartman, Linda
    Malander, Susanne
    Kannisto, Paivi
    Masback, Anna
    Hedenfalk, Ingrid
    VIRCHOWS ARCHIV, 2020, 477 (01) : 83 - 91
  • [5] PD-1/PD-L1 EXPRESSION AND TUMOR-INFILTRATING LYMPHOCYTES ARE PROGNOSTICALLY FAVORABLE IN HIGH-GRADE SEROUS OVARIAN CANCER
    de la Fuente, L. Martin
    Fremer, S. Westbom
    Arildsen, N. Skovbjerg
    Hartman, L.
    Malander, S.
    Kannisto, P.
    Masback, A.
    Hedenfalk, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 761 - 761
  • [6] PD-L1 Expression in High-Grade Serous and Clear Cell Ovarian Cancer
    Ljubiša Jovanović
    Andja Ćirković
    Milena Jović
    Radmila Janković
    Indian Journal of Gynecologic Oncology, 2022, 20
  • [7] PD-L1 Expression in High-Grade Serous and Clear Cell Ovarian Cancer
    Jovanovic, Ljubisa
    Cirkovic, Andja
    Jovic, Milena
    Jankovic, Radmila
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2022, 20 (04)
  • [8] Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer
    Wan, Changxin
    Keany, Matthew P.
    Dong, Han
    Al-Alem, Linah F.
    Pandya, Unnati M.
    Lazo, Suzan
    Boehnke, Karsten
    Lynch, Katherine N.
    Xu, Rui
    Zarrella, Dominique T.
    Gu, Shengqing
    Cejas, Paloma
    Lim, Klothilda
    Long, Henry W.
    Elias, Kevin M.
    Horowitz, Neil S.
    Feltmate, Colleen M.
    Muto, Michael G.
    Worley, Michael J.
    Berkowitz, Ross S.
    Matulonis, Ursula A.
    Nucci, Marisa R.
    Crum, Christopher P.
    Rueda, Bo R.
    Brown, Myles
    Liu, Xiaole Shirley
    Hill, Sarah J.
    CANCER RESEARCH, 2021, 81 (01) : 158 - 173
  • [9] Combined PD-1/PD-L1 and tumor-infiltrating immune cells redefined a unique molecular subtype of high-grade serous ovarian carcinoma
    Liu, Ping
    Chen, Ruoxu
    Zhang, Xudong
    Fu, Ruiting
    Tao, Lin
    Jia, Wei
    BMC GENOMICS, 2022, 23 (01)
  • [10] Combined PD-1/PD-L1 and tumor-infiltrating immune cells redefined a unique molecular subtype of high-grade serous ovarian carcinoma
    Ping Liu
    Ruoxu Chen
    Xudong Zhang
    Ruiting Fu
    Lin Tao
    Wei Jia
    BMC Genomics, 23
12345